Gene · 4320
MMP11: matrix metallopeptidase 11
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MMP11: matrix metallopeptidase 11. Genes, record 4320. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4320
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P24347 | Stromelysin-3 | 488 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents45
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4824266 A1 | 2026-10-21 | 74 | P24347 | Espacenet |
| EP 4773979 A1 | 2026-07-15 | 194 | P24347 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 275 | P24347 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 8765 | P24347 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7043 | P24347 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7043 | P24347 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 275 | P24347 | Espacenet |
| JP 2025512333 A | 2025-04-17 | 822 | P24347 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 8765 | P24347 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 8765 | P24347 | Espacenet |
1 to 10 of 45
See all 45 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,360
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MMP11 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| ZIAHD001901 | Molecular mechanism of thyroid hormone receptor function during metamorphosis | 7 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 5 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 5 | 2025 |
| P50CA116201 | Mayo Clinic Breast Cancer SPORE | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| U54CA118638 | 1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,360Source NIH's project files
See all 1,360 nih grantsPapers3,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA sequencing in diabetic foot ulcers: pathogenesis, biomarkers, and translational potential. | Front Clin Diabetes Healthc | 2026 | 42757034 | PubTator, text mining | PubMed |
| A Composite Histopathologic Invasion Score Predicts Lymph Node Metastasis in Gastric Cancer. | J Clin Med | 2026 | 42739515 | PubTator, text mining | PubMed |
| Single-cell transcriptomics deciphers cancer-associated fibroblast heterogeneity and immune regulatory mechanisms in the bladder cancer tumor microenvironment. | Front Cell Dev Biol | 2026 | 42729537 | PubTator, text mining | PubMed |
| Clinical Significance of Tumor Invasion Gene Profiling in Early-Stage Hormone Receptor-Positive Breast Cancer: A Cross-Sectional Study. | Health Sci Rep | 2026 | 42416217 | PubTator, text mining | PubMed |
| Distinct Molecular Signature of Earlobe Keloids: Integrated Transcriptomic Analysis of Extracellualr Matrix, Metalloproteinase, and Metabolic Pathways. | Aesthetic Plast Surg | 2026 | 42414644 | PubTator, text mining | PubMed |
| Dissection of the EIAV Core Packaging Region Identifies SL2 Stem and SL2-SL3 Junction as Gag-Associated Packaging Determinants and Antiviral Targets. | Int J Mol Sci | 2026 | 42278261 | PubTator, text mining | PubMed |
| Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer. | J Immunother Cancer | 2026 | 42173653 | PubTator, text mining | PubMed |
| Remdesivir and Favipiravir as potential antivirals for poliovirus: In vitro efficacy and RNA-dependent RNA polymerase binding analysis. | Virology | 2026 | 42150251 | PubTator, text mining | PubMed |
| Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expression. | Front Immunol | 2026 | 42148109 | PubTator, text mining | PubMed |
| TAPINTO: A Novel Algorithm for Tumor-Associated Antigen Prediction Based on Information about Target Overexpression. | Comput Struct Biotechnol J | 2026 | 42146903 | PubTator, text mining | PubMed |
1 to 10 of 3,235
See all 3,235 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4320
GET https://conductscience.org/api/genes/v1/4320/patents?page=2